Novel role for protein kinase D in airway inflammation and antiviral immunity
蛋白激酶 D 在气道炎症和抗病毒免疫中的新作用
基本信息
- 批准号:10359734
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-13 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:ActinsAttenuatedCCRCXCL1 geneCellsChemotactic FactorsComplexCytokine GeneDouble-Stranded RNAEpithelialEpithelial CellsEquilibriumFunctional disorderGene ExpressionGenesGenetic TranscriptionImmune responseImmune systemImmunityIn VitroInfectionInflammationInfluenzaInfluenza A virusInhalationInnate Immune ResponseInterferonsKnockout MiceLightLinkLungMAP3K7 geneMediatingModelingMorbidity - disease rateMusNF-kappa BNatural ImmunityNeutrophil InfiltrationPattern recognition receptorPhosphorylationProtein DephosphorylationProtein IsoformsProtein-Serine-Threonine KinasesProteinsPulmonary InflammationRoleSignal PathwaySignal TransductionSmall Interfering RNATBK1 geneTLR3 geneTestingTight JunctionsTretinoinViralVirusVirus DiseasesVirus Replicationairway epitheliumairway inflammationantagonistantiviral immunitybasecell motilitychemokinechemokine receptorcofilinconditional knockoutcytokinehelicasein vivoinfluenza infectioninfluenza pneumoniainhibitorinterstitialknock-downlung injurymelanomamigrationmortalityneutrophilnovelprotein kinase Drespiratory virussensortranscription factor
项目摘要
Respiratory viruses are a major cause of morbidity and mortality worldwide. After infecting their target
cells, viruses are sensed by different pattern recognition receptors (PRR’s) that initiate innate anti-viral
immune responses. Viral double stranded RNA (dsRNA) is a potent stimulator of innate immunity and
activates toll-like receptor 3 (TLR3) as well as the intracellular helicases RIG-I (retinoic acid-inducible
gene I) and MDA5 (melanoma differentiation-associated protein 5). Double stranded RNA sensors
are expressed by the airway epithelium, and couple to complex downstream signaling pathways that
initiate the expression of interferons and cytokine genes, resulting in airway inflammation and
induction of anti-viral immunity. This R01 application is based on our serendipitous discovery that the
serine/threonine kinase protein kinase D (PKD) has a previously overlooked role in innate immune
responses driven by the dsRNA polyI:C. There are three PKD isoforms (PKD1-3), but little is known
about their expression or function in the lung. Using targeted siRNA knock-down and a new line of
knock-out mice, we found that polyI:C-induced epithelial cytokine gene expression and neutrophil
recruitment to the lung are both dependent on PKD3. This appears to involve a previously unreported
role for PKD3 in polyI:C signaling in epithelial cells, as well as in chemokine receptor signal
transduction in neutrophils. Excitingly, we also discovered that a potent and selective PKD antagonist
protects mice from infection with influenza A virus (IAV). In this revised R01 application, we propose
three Aims that will: explain exactly how PKD mediates dsRNA signal transduction in airway epithelial
cells (Aim 1), use conditional deletion and other strategies to unravel a new neutrophil specific role for
PKD3 in lung inflammation (Aim 2), and test the hypothesis that targeting PKD will attenuate lung
inflammation after influenza infection in mice (Aim 3).
呼吸道病毒是全世界发病率和死亡率的主要原因。在感染目标后
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steve N Georas其他文献
Steve N Georas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steve N Georas', 18)}}的其他基金
Novel role for protein kinase D in airway inflammation and antiviral immunity
蛋白激酶 D 在气道炎症和抗病毒免疫中的新作用
- 批准号:
10576337 - 财政年份:2020
- 资助金额:
$ 38.5万 - 项目类别:
EPITHELIAL BARRIER DYSFUNCTION AND MUCOSAL INFLAMMATION IN ASTHMA
哮喘中的上皮屏障功能障碍和粘膜炎症
- 批准号:
9130246 - 财政年份:2014
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
7984934 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
8127904 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
7154129 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
8267672 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
6987168 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
8471746 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
6839462 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
LPA and Edg Receptors in the Pulmonary Immune Respose
LPA 和 Edg 受体在肺免疫反应中的作用
- 批准号:
6733798 - 财政年份:2004
- 资助金额:
$ 38.5万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 38.5万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 38.5万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 38.5万 - 项目类别:
Idea to Innovation